These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12077937)
1. [Sparfloxacin (a long-acting difluoroquinolone)--an antibacterial preparation with the broad spectrum activity]. Padeĭskaia EN Antibiot Khimioter; 2002; 47(1):26-35. PubMed ID: 12077937 [No Abstract] [Full Text] [Related]
2. [A broad-spectrum antimicrobial preparation--lomefloxacin (Maxaquin): the results of 10 years of its use in the clinics of Russia]. Padeĭskaia EN Antibiot Khimioter; 2000; 45(1):39-44. PubMed ID: 10690427 [No Abstract] [Full Text] [Related]
3. [Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin]. Jpn J Antibiot; 1994 Oct; 47(10):1241-58. PubMed ID: 7807686 [No Abstract] [Full Text] [Related]
4. [A randomized controlled clinical study of sparfloxacin versus ofloxacin in the treatment of bacterial infections]. Hu P; Zou Q; Jiang Y; Wang Q; Jiang S; Hu D; Zhu L; Li S Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):22-6. PubMed ID: 11798621 [TBL] [Abstract][Full Text] [Related]
5. Is more than one quinolone needed in clinical practice? Paladino JA Ann Pharmacother; 2001 Sep; 35(9):1085-95. PubMed ID: 11573860 [TBL] [Abstract][Full Text] [Related]
6. The fluoroquinolones. Walker RC Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871 [TBL] [Abstract][Full Text] [Related]
7. [Fluoroquinolones--a current review]. Christ W; Kemmler H Med Monatsschr Pharm; 2001 Jul; 24(7):215-25. PubMed ID: 11486553 [No Abstract] [Full Text] [Related]
8. The fluoroquinolones after ciprofloxacin and ofloxacin. Hooper DC Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519 [No Abstract] [Full Text] [Related]
9. [Clinical and laboratory efficacy of the novel difluoroquinolone Sparflo (sparfloxacin) in therapy of skin and soft tissue infections]. Iakovlev VP; Krutikov MG; Blatun LA; Izotova GN; Grishina IA Antibiot Khimioter; 2000; 45(12):37-40. PubMed ID: 11212495 [TBL] [Abstract][Full Text] [Related]
10. [Fluoroquinolones--current value in antibacterial therapy, outlook for development]. Navashin SM; Navashin PS Antibiot Khimioter; 1996; 41(9):4-10. PubMed ID: 9005784 [No Abstract] [Full Text] [Related]
11. The quinolones and renal infection. Ronald A Drugs; 1999; 58 Suppl 2():96-8. PubMed ID: 10553715 [TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolones. Molavi A Am Fam Physician; 1988 May; 37(5):279-84. PubMed ID: 3284309 [No Abstract] [Full Text] [Related]
13. Sparfloxacin and levofloxacin. Med Lett Drugs Ther; 1997 Apr; 39(999):41-3. PubMed ID: 9137295 [No Abstract] [Full Text] [Related]
14. Pharmacokinetic and clinical studies of T-3761 in otorhinolaryngeal infections. Shinkawa A; Kimura H; Sakai M; Miyake H Drugs; 1995; 49 Suppl 2():401-2. PubMed ID: 8549377 [No Abstract] [Full Text] [Related]
15. [The place of fluoroquinolones in the treatment of bacterial infections]. Iakovlev SV Antibiot Khimioter; 1999; 44(12):27-30. PubMed ID: 10687031 [No Abstract] [Full Text] [Related]
16. Safety profile of sparfloxacin, a new fluoroquinolone antibiotic. Lipsky BA; Dorr MB; Magner DJ; Talbot GH Clin Ther; 1999 Jan; 21(1):148-59. PubMed ID: 10090432 [TBL] [Abstract][Full Text] [Related]
17. [Fluoroquinolones, 10 years later]. de la Blanchardière A; Carbon C Rev Prat; 1993 Sep; 43(14):1830-8. PubMed ID: 8310228 [TBL] [Abstract][Full Text] [Related]